{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:32:49Z","timestamp":1766428369825},"reference-count":174,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2002,1,15]]},"DOI":"10.1086\/324744","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T13:29:04Z","timestamp":1027690144000},"page":"248-259","source":"Crossref","is-referenced-by-count":44,"title":["Clinical Evaluation and Management of Metabolic and Morphologic Abnormalities Associated with Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"34","author":[{"given":"Christine\u00a0A.","family":"Wanke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian\u00a0M.","family":"Falutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abby","family":"Shevitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John\u00a0P.","family":"Phair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald\u00a0P.","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"rf1_518","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11443-X"},{"key":"rf2_519","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199815000-00001"},{"key":"rf3_520","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"rf4_521","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11518-5"},{"key":"rf5_522","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/dmr.5610040607","volume":"4","author":"Bjorntorp P","year":"1988","journal-title":"Diabetes Metab Rev"},{"key":"rf6_523","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.288.6428.1401","volume":"288","author":"Larsson B","year":"1984","journal-title":"BMJ"},{"key":"rf7_524","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199200111-00002","volume":"20","author":"DeFronzo RA","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"rf8_525","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.37.12.1595"},{"key":"rf9_526","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.98.5.398","volume":"98","author":"Pyorala M","year":"1998","journal-title":"Circulation"},{"key":"rf10_527","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.24.1955"},{"key":"rf11_528","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00494.x","volume":"231","author":"Laws A","year":"1992","journal-title":"J Intern Med"},{"key":"rf12_529","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90041-U"},{"key":"rf13_530","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90173-K"},{"key":"rf14_531","first-page":"358","volume":"8","author":"Howard G","year":"1998","journal-title":"Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol"},{"key":"rf15_532","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.2.221"},{"key":"rf16_533","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/bmj.303.6805.755","volume":"303","author":"Skarfors ET","year":"1991","journal-title":"BMJ"},{"key":"rf17_534","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2337\/diab.42.11.1555","volume":"42","author":"American Diabetes Association","year":"1993","journal-title":"Diabetes"},{"key":"rf18_535","unstructured":"Geiss LS, Herman WH, Smith PJ, eds. Mortality in non-insulin dependent diabetes mellitus. Washington, DC: Government Printing Office, 1995."},{"key":"rf19_536","first-page":"1125","author":"Farmer JA","year":"1992","journal-title":"Philadelphia: WB Saunders"},{"key":"rf20_537","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM198602203140806","volume":"314","author":"Ross R","year":"1986","journal-title":"N Engl J Med"},{"key":"rf21_538","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90550-I"},{"key":"rf22_539","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00159-2"},{"key":"rf23_540","first-page":"263","volume":"31","author":"Lewis B","year":"1997","journal-title":"J R Coll Physicians Lond"},{"key":"rf24_541","doi-asserted-by":"publisher","DOI":"10.1001\/jama.251.3.365"},{"key":"rf25_542","first-page":"600","volume":"8403","author":"Oliver MF","year":"1984","journal-title":"Report of the Committee of Principal Investigators. Lancet"},{"key":"rf26_543","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","volume":"317","author":"Frick MH","year":"1987","journal-title":"N Engl J Med"},{"key":"rf27_544","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511163332001"},{"key":"rf28_545","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.20.1615"},{"key":"rf29_546","doi-asserted-by":"publisher","DOI":"10.1001\/jama.276.7.544"},{"key":"rf30_547","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ajcn\/55.6.1033","volume":"55","author":"Spiegelman D","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"rf31_548","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-1002768","volume":"14","author":"Schaefer EJ","year":"1988","journal-title":"Semin Thromb Hemost"},{"key":"rf32_549","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/ajcn\/52.5.946","volume":"52","author":"Bouchard C","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"rf33_550","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.STR.21.5.701","volume":"21","author":"Folsom AR","year":"1990","journal-title":"Stroke"},{"key":"rf34_551","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/01.ATV.10.4.497","volume":"10","author":"Despres JP","year":"1990","journal-title":"Arteriosclerosis"},{"key":"rf35_552","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/oxfordjournals.aje.a009158","volume":"145","author":"Carey VJ","year":"1997","journal-title":"Am J Epidemiol"},{"key":"rf36_553","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.ATV.8.1.88","volume":"8","author":"Anderson AJ","year":"1988","journal-title":"Arteriosclerosis"},{"key":"rf37_554","first-page":"79","volume":"723","author":"Kissebah AH","year":"1988","journal-title":"Acta Med Scand Suppl"},{"key":"rf38_555","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/bmj.289.6454.1257","volume":"289","author":"Lapidus L","year":"1984","journal-title":"Sweden. BMJ"},{"key":"rf39_556","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)10004-6"},{"key":"rf40_557","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1997.00235.x"},{"key":"rf41_558","first-page":"397","volume":"18","author":"Caan B","year":"1994","journal-title":"Int J Obes Relat Metab Disord"},{"key":"rf42_559","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/07853899209164140","volume":"24","author":"Bjorntorp P","year":"1992","journal-title":"Ann Med"},{"key":"rf43_560","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90676-9"},{"key":"rf44_561","first-page":"420","volume":"4","author":"Vague J","year":"1956","journal-title":"J Clin Invest"},{"key":"rf45_562","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/oxfordjournals.aje.a117385","volume":"141","author":"Rimm EB","year":"1995","journal-title":"Am J Epidemiol"},{"key":"rf46_563","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1843"},{"key":"rf47_564","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.34.10.1055"},{"key":"rf48_565","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199903110-00004"},{"key":"rf49_566","doi-asserted-by":"publisher","DOI":"10.1086\/317491"},{"key":"rf50_567","doi-asserted-by":"publisher","DOI":"10.1086\/313854"},{"key":"rf51_568","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200110190-00003"},{"key":"rf52_569","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199713000-00014"},{"key":"rf53_570","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60295-4"},{"key":"rf54_571","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(90)90136-Z"},{"key":"rf55_572","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(91)90059-6"},{"key":"rf56_573","doi-asserted-by":"crossref","unstructured":"Caldwell R, Rothstein A, Allmon C, Montoya JG, Zolopa A. Evaluation of protease-inhibitor associated hyperglycemia in a university-based HIV clinic [abstract 12395]. In: Program and abstracts of the 12th World AIDS Conference (Geneva), Stockholm: International AIDS Society, 1998.","DOI":"10.1097\/00002030-199815000-00023"},{"key":"rf57_574","unstructured":"Lumpkin M. Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus infection. United States Food and Drug Association (USFDA) Public Health Advisory. Washington, DC: USFDA, 11 June 1997."},{"key":"rf58_575","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.13.2050"},{"key":"rf59_576","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63513-1"},{"key":"rf60_577","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907090-00001"},{"key":"rf61_578","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912240-00002"},{"key":"rf62_579","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.6.1925"},{"key":"rf63_580","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-200001010-00005","volume":"23","author":"Mulligan K","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf64_581","doi-asserted-by":"crossref","unstructured":"Noor M, Lo J, Halvorsen R, Schwarz JW, Schambelan M, Grunfeld C. Metabolic effects of indinavir in healthy HIV-seronegative subjects [abstract 010]. In: Program and abstracts of the Second International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (Toronto), 2000.","DOI":"10.1097\/00002030-200105040-00001"},{"key":"rf65_582","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"key":"rf66_583","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19231"},{"key":"rf67_584","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-127-10-199711150-00016","volume":"127","author":"Visnegarwala F","year":"1997","journal-title":"Ann Intern Med"},{"key":"rf68_585","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200012010-00004"},{"key":"rf69_586","first-page":"929","volume":"45","author":"Aggarwal A","year":"1996","journal-title":"Md Med J"},{"key":"rf70_587","doi-asserted-by":"publisher","DOI":"10.1086\/313912"},{"key":"rf71_588","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80020-8"},{"key":"rf72_589","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90225-8"},{"key":"rf73_590","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.5.1045"},{"key":"rf74_591","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332303"},{"key":"rf75_592","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)00022-1"},{"key":"rf76_593","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","volume":"100","author":"Periard D","year":"1999","journal-title":"Circulation"},{"key":"rf77_594","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001070-00006"},{"key":"rf78_595","first-page":"2044","volume":"92","author":"Dutta SK","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"rf79_596","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00169-2"},{"key":"rf80_597","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80370-2"},{"key":"rf81_598","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80431-7"},{"key":"rf82_599","doi-asserted-by":"crossref","unstructured":"Perry RC, Cushing HE, Deeg MA, Prince MJ. Ritonavir, triglycerides, and pancreatitis. Clin Infect Dis 1999; 28:161-2.","DOI":"10.1086\/517194"},{"key":"rf83_600","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62957-1"},{"key":"rf84_601","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64011-1"},{"key":"rf85_602","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/517682","volume":"27","author":"Striker R","year":"1998","journal-title":"Clin Infect Dis"},{"key":"rf86_603","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)70281-6"},{"key":"rf87_604","unstructured":"Muurahainen N, Santos G, Kleintop M, etal Gender differences in HIV-associated adipose redistribution syndrome (HARS): an update [abstract 26]. In: Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf88_605","unstructured":"Lichtenstein K, Ward D, Delaney K, etal Clinical factors related to the severity of fat redistribution in the HIV outpatient study (HOPS) [abstract 23]. In: 7th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf89_606","unstructured":"Kotler DP. Fat redistribution and metabolic abnormalities. Available at Medscape. Accessed August 2001."},{"key":"rf90_607","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/00002030-200001070-00007","volume":"14","author":"Muurahainen N","year":"2000","journal-title":"AIDS"},{"key":"rf91_608","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001070-00005"},{"key":"rf92_609","doi-asserted-by":"publisher","DOI":"10.1086\/317541"},{"key":"rf93_610","unstructured":"Sosman JM, Klein MA, Bellhumeur JL, Aeschlimann SE, Stein H. Endothelial dysfunction is associated with the use of human immunodeficiency virus-1 protease inhibitors [abstract 29]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf94_611","unstructured":"Cheminot N, Gariepy J, Chironi G, Scaut L, Vittecoq D. Diagnosis and determination of subclinical arterial disease in HIV patients on HAART [abstract 31]. In: Program and abstracts of 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf95_612","unstructured":"Kosmiski L, Kuritzkes D, Lichtenstein K, Greenberg K, Ehrlich J, Eckel RH. An increase in abdominal girth on protease inhibitor therapy is associated with visceral obesity and metabolic disturbances that closely resemble syndrome X [abstract 056]. In: Program and abstracts of the 1st International Workshop in Adverse Drug Reactions and Lipodystrophy in HIV (San Diego), 1999."},{"key":"rf96_613","unstructured":"Depairon M, Chessex S, Telenti A, etal Noninvasive morphological analysis of carotid and femoral arteries in protease inhibitor treated HIV-infected individuals [abstract 30]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf97_614","unstructured":"Currier JS, Johnson DL, Dube M, Hodis H. A pilot study of carotid intima media thickness (IMT) in HIV-infected women treated with protease inhibitors [abstract 32]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf98_615","unstructured":"Lenormand-Walckneaer C, Joly V, Matheron S, Chemlal K, Prevot MH, Leguludec D. Detection of myocardial ischemia in protease inhibitor-treated HIV-infected patients with hyperlipidemia [abstract 35]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf99_616","unstructured":"Klein D, Hurley L, Sorel M, Sidney S. Do protease inhibitors increase the risk for coronary heart disease among HIV-positive patients-follow-up through June 2000 [abstract 655]. In: Program and abstracts of the 8th International Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2001."},{"key":"rf100_617","unstructured":"Coplan P, Cormier K, Japour A, etal Myocardial infarction incidence in clinical trials of 4 protease inhibitors [abstract 34]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf101_618","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)26026-0"},{"key":"rf102_619","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78644-X"},{"key":"rf103_620","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78643-8"},{"key":"rf104_621","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79053-X"},{"key":"rf105_622","unstructured":"Mary-Krause M, Cotte L, Partisani M, Simon A, Costagliola D. Impact of treatment with protease inhibitor on myocardial infarction occurrence in HIV-infected men [abstract 657]. In: Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2001."},{"key":"rf106_623","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/514637","volume":"27","author":"Hirsch MS","year":"1998","journal-title":"Clin Infect Dis"},{"key":"rf107_624","first-page":"17","volume":"5","author":"Powderly WG","year":"2000","journal-title":"Antivir Ther"},{"key":"rf108_625","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.14.9.796"},{"key":"rf109_626","doi-asserted-by":"crossref","first-page":"A40S","DOI":"10.1016\/S0002-9343(96)00319-1","volume":"101","author":"Stone NJ","year":"1996","journal-title":"Am J Med"},{"key":"rf110_627","first-page":"S45","volume":"47","author":"Nuttall FQ","year":"1998","journal-title":"J Fam Pract"},{"key":"rf111_628","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM198807213190311","volume":"319","author":"Wood PD","year":"1988","journal-title":"N Engl J Med"},{"key":"rf112_629","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM199108153250703","volume":"325","author":"Wood PD","year":"1991","journal-title":"N Engl J Med"},{"key":"rf113_630","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800834"},{"key":"rf114_631","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/01.HYP.11.3.244","volume":"11","author":"Parillo M","year":"1988","journal-title":"Hypertension"},{"key":"rf115_632","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.3.e26"},{"key":"rf116_633","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.1.10"},{"key":"rf117_634","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.4.562"},{"key":"rf118_635","doi-asserted-by":"publisher","DOI":"10.1001\/jama.254.7.919"},{"key":"rf119_636","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(98)00068-0"},{"key":"rf120_637","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-133-2-200007180-00008","volume":"133","author":"Ross R","year":"2000","journal-title":"Ann Intern Med"},{"key":"rf121_638","unstructured":"McArdle WD, Katch FI, Katch VL. Exercise physiology: energy, nutrition, and human performance. Philadelphia: Lea & Febiger, 1996."},{"key":"rf122_639","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1152\/jappl.1999.86.4.1197","volume":"86","author":"Roubenoff R","year":"1999","journal-title":"J Appl Physiol"},{"key":"rf123_640","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907300-00015"},{"key":"rf124_641","unstructured":"DeFronzo RA. Current management of diabetes mellitus. Baltimore, MD: Mosby, 1998."},{"key":"rf125_642","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-131-3-199908030-00004","volume":"131","author":"Aviles-Santa L","year":"1999","journal-title":"Ann Intern Med"},{"key":"rf126_643","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.43.7.920"},{"key":"rf127_644","doi-asserted-by":"crossref","unstructured":"Bailey CJ, Nattrass M. Treatment-metformin. Baillieres Clin Endocrinol Metab 1988; 2:455-76.","DOI":"10.1016\/S0950-351X(88)80043-0"},{"key":"rf128_645","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.9.920"},{"key":"rf129_646","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-73-6-1294","volume":"73","author":"DeFronzo RA","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"rf130_647","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905280-00023"},{"key":"rf131_648","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.472"},{"key":"rf132_649","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.6.925"},{"key":"rf133_650","unstructured":"Glucophage [package insert]. Princeton, NJ: Bristol-Meyers Squibb, 1999."},{"key":"rf134_651","unstructured":"Walli R, Michl M, Bogner J, Goebel F. Effects of the PPAR-gamma activator troglitazone on protease inhibitor associated peripheral insulin resistance [abstract 673]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 1999."},{"key":"rf135_652","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/0003-4819-132-2-200001180-00005","volume":"132","author":"Forman LM","year":"2000","journal-title":"Ann Intern Med"},{"key":"rf136_653","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-132-2-200001180-00006","volume":"132","author":"Al-Salman J","year":"2000","journal-title":"Ann Intern Med"},{"key":"rf137_654","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.83.6.2154","volume":"83","author":"National Cholesterol Education Program","year":"1991","journal-title":"Circulation"},{"key":"rf138_655","doi-asserted-by":"publisher","DOI":"10.1086\/317429"},{"key":"rf139_656","unstructured":"Fichtenbaum C, Gerber J, Rosenkranz S, etal Pharmacokinetic interactions between protease inhibitors and selected HMG-CoA reductase inhibitors [abstract LB6]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf140_657","doi-asserted-by":"publisher","DOI":"10.1177\/00912700022008874"},{"key":"rf141_658","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(98)00016-3"},{"key":"rf142_659","unstructured":"Ruiz L, Negredo E, Domingo P, etal Clinical, virological, and immunological benefit of switching the protease inhibitor (PI) by nevirapine in HAART-experienced patient suffering lipodystrophy (LD): 36 week followup [abstract 206] In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf143_660","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905070-00009"},{"key":"rf144_661","unstructured":"Martinez E, Blanco JL, Garcia MA, etal Impact of switching from HIV-1 protease inhibitors (PI) to efavirenz in patients with lipodystrophy [abstract 50]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf145_662","first-page":"78","volume":"5","author":"Yarasheski KE","year":"2000","journal-title":"Antivir Ther"},{"key":"rf146_663","first-page":"78","volume":"5","author":"Yarasheski KE","year":"2000","journal-title":"Antivir Ther"},{"key":"rf147_664","unstructured":"Rozenbaum W, Molina JM, Delfraissy JF, Bentata M, De Truchis P, Antoun Z. Improvement of lipodystrophy in HIV-1 infected subjects switching from 2NRTI\/PI to 2NRTI\/abacavir (French substudy, CNA30017) [abstract 47]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf148_665","unstructured":"Goebel F, Walli K. A novel use of abacavir to simplify therapy in PI-experienced patients successfully treated with HAART: CNA30017 [abstract 51]. In: Program and abstracts of the 7th International Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, Virginia: Foundation for Retrovirology and Human Health, 2000."},{"key":"rf149_666","first-page":"162","volume":"10","author":"Currier JS","year":"2000","journal-title":"AIDS Read"},{"key":"rf150_667","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907300-00004"},{"key":"rf151_668","first-page":"991","volume":"16","author":"Marin P","year":"1992","journal-title":"Int J Obes Relat Metab Disord"},{"key":"rf152_669","unstructured":"Dieterich D, Aymat R, Braun J, etal Incidence of body habitus changes in a cohort of 725 HIV-infected patients [abstract 674]. In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections (Chicago). 1999."},{"key":"rf153_670","first-page":"64","volume":"5","author":"McComsey G","year":"2000","journal-title":"Antivir Ther"},{"key":"rf154_671","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(94)90049-3"},{"key":"rf155_672","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(80)90159-6"},{"key":"rf156_673","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607043350101"},{"key":"rf157_674","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603143341107"},{"key":"rf158_675","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-6374(99)80006-9"},{"key":"rf159_676","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/ajcn\/61.6.1290","volume":"61","author":"Snel YE","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"rf160_677","first-page":"2","volume":"128","author":"Bengtsson BA","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"rf161_678","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(96)90292-9"},{"key":"rf162_679","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90145-E"},{"key":"rf163_680","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.2.453"},{"key":"rf164_681","first-page":"8","volume":"5","author":"Rietschel P","year":"2000","journal-title":"Antivir Ther"},{"key":"rf165_682","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199910220-00013"},{"key":"rf166_683","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912030-00023"},{"key":"rf167_684","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/0003-4819-131-4-199908170-00024","volume":"131","author":"Mauss S","year":"1999","journal-title":"Ann Intern Med"},{"key":"rf168_685","unstructured":"Engelhard P, Strawbridge T. The use of growth hormone (Serostim) in patients with HIIV-associated adipose redistribution syndrome (HARS) [abstract TuPeB3151]. In: Program and abstracts of the 13th International AIDS Conference (Durban, South Africa). Stockholm: International AIDS Society, 2000."},{"key":"rf169_686","unstructured":"Furrer H, Nguyen QV, Malinverni R. Treatment of HAART associated fat accumulation disease with recombinant human growth hormone: results of a randomized double blind placebo controlled crossover trial [abstract LbPp114]. In: Program and abstracts of the13th International AIDS Conference (Durban, South Africa). Stockholm: International AIDS Society, 2000."},{"key":"rf170_687","unstructured":"Engelson ES, Glesby M, Sheikan J, Mendez D, Wang J, Kotler DP. Body composition changes during and after growth hormone therapy for lipodystrophy with truncal adiposity [abstract ThPpB1437]. In: Program and abstracts of the 13th International AIDS Conference (Durban, South Africa). Stockholm: International AIDS Society, 2000."},{"key":"rf171_688","first-page":"19","volume":"4","author":"Engelson ES","year":"1999","journal-title":"Antivir Ther"},{"key":"rf172_689","first-page":"80","volume":"5","author":"Engelson ES","year":"2000","journal-title":"Antivir Ther"},{"key":"rf173_690","first-page":"9","volume":"5","author":"Lo JC","year":"2000","journal-title":"Antivir Ther"},{"key":"rf174_691","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.2337\/diacare.24.1.1","volume":"24","year":"2001","journal-title":"Diabetes Care"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/34\/2\/248\/887659\/34-2-248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T22:58:52Z","timestamp":1583276332000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/324744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,15]]},"references-count":174,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,1,15]]}},"alternative-id":["10.1086\/324744"],"URL":"https:\/\/doi.org\/10.1086\/324744","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,15]]}}}